Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044453
Filing Date
2021-08-16
Accepted
2021-08-16 08:01:12
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vcnx-10q_20210630.htm   iXBRL 10-Q 1897947
2 EX-31.1 vcnx-ex311_35.htm EX-31.1 22166
3 EX-31.2 vcnx-ex312_36.htm EX-31.2 22036
4 EX-32.1 vcnx-ex321_37.htm EX-32.1 10852
  Complete submission text file 0001564590-21-044453.txt   6596599

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20210630.xsd EX-101.SCH 50711
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vcnx-20210630_cal.xml EX-101.CAL 33868
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcnx-20210630_def.xml EX-101.DEF 178287
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20210630_lab.xml EX-101.LAB 381918
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20210630_pre.xml EX-101.PRE 306544
10 EXTRACTED XBRL INSTANCE DOCUMENT vcnx-10q_20210630_htm.xml XML 1005157
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38624 | Film No.: 211174602
SIC: 2834 Pharmaceutical Preparations